Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Chugai claims new antiestrogens that inhibit osteoclast differentiation

Nov. 24, 2003

Second of three dose levels of Oxycyte completed in phase I study

Nov. 21, 2003

Potent, selective, nonpeptide MCH1 receptor antagonist with anorexic activity

Nov. 20, 2003

NDA submitted for ezetimibe/simvastatin

Nov. 20, 2003

Icatibant awarded orphan drug status for angioedema

Nov. 20, 2003

Novel GH secretagogues, their preparation and use, claimed by Lilly

Nov. 20, 2003

New antidiabetic agent from plant origin identified by Indian researchers

Nov. 19, 2003

New cathepsin K inhibitors prepared and tested by GSK scientists

Nov. 19, 2003

Anandamide and oleamide increase food intake in rats

Nov. 19, 2003

Good safety profile found for pyridoxamine in patients with diabetic nephropathy

Nov. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...